Shari Annes | IR |
Harout Semerjian | CEO |
Brian Hahn | CFO |
Armand Girard | Chief Business Officer |
Ed White | H.C. Wainwright |
Boris Peaker | Cowen |
Roger Song | Jefferies |
Zegbeh Jallah | ROTH Capital Partners |
Good morning, and thank you for joining the GlycoMimetics Call. [Operator Instructions] I’d now like to turn the call over to Shari Annes of Investor Relations Group of GlycoMimetics. Please go ahead.
Good morning. Today, we will review our accomplishments and financial results for the quarter ended March 31, 2022.